ZUMA-3: CAR T Therapy for Adult Patients With ALL - Episode 6

The Potential Future Impact of CAR T Cell Therapy in Adult ALL


Experts in hematology oncology consider unmet needs for adult patients with relapsed/refractory ALL and reflect on the potential impact that FDA approval of CAR T cell therapy would have on the treatment landscape.